chr2-74490046-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_022492.6(TTC31):​c.151C>G​(p.Arg51Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000192 in 1,559,964 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

TTC31
NM_022492.6 missense

Scores

1
3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.327

Publications

1 publications found
Variant links:
Genes affected
TTC31 (HGNC:25759): (tetratricopeptide repeat domain 31)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TTC31NM_022492.6 linkc.151C>G p.Arg51Gly missense_variant Exon 3 of 13 ENST00000233623.11 NP_071937.4 Q49AM3-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TTC31ENST00000233623.11 linkc.151C>G p.Arg51Gly missense_variant Exon 3 of 13 1 NM_022492.6 ENSP00000233623.6 Q49AM3-1

Frequencies

GnomAD3 genomes
AF:
0.00000659
AC:
1
AN:
151664
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000112
AC:
2
AN:
177980
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000765
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000142
AC:
2
AN:
1408300
Hom.:
0
Cov.:
35
AF XY:
0.00
AC XY:
0
AN XY:
695958
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
32356
American (AMR)
AF:
0.0000543
AC:
2
AN:
36822
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25034
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37252
South Asian (SAS)
AF:
0.00
AC:
0
AN:
80724
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49744
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5636
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1082570
Other (OTH)
AF:
0.00
AC:
0
AN:
58162
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.450
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00000659
AC:
1
AN:
151664
Hom.:
0
Cov.:
32
AF XY:
0.0000135
AC XY:
1
AN XY:
74062
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41298
American (AMR)
AF:
0.0000656
AC:
1
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4776
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10484
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
314
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67924
Other (OTH)
AF:
0.00
AC:
0
AN:
2082
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000756

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 24, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.151C>G (p.R51G) alteration is located in exon 3 (coding exon 3) of the TTC31 gene. This alteration results from a C to G substitution at nucleotide position 151, causing the arginine (R) at amino acid position 51 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.37
CADD
Benign
16
DANN
Uncertain
0.98
DEOGEN2
Benign
0.013
.;.;T
Eigen
Benign
-0.54
Eigen_PC
Benign
-0.68
FATHMM_MKL
Benign
0.078
N
LIST_S2
Benign
0.76
T;T;T
M_CAP
Benign
0.0039
T
MetaRNN
Benign
0.13
T;T;T
MetaSVM
Benign
-0.99
T
MutationAssessor
Benign
1.8
L;.;L
PhyloP100
-0.33
PrimateAI
Benign
0.28
T
PROVEAN
Uncertain
-3.2
.;D;N
REVEL
Benign
0.068
Sift
Uncertain
0.0080
.;D;D
Sift4G
Pathogenic
0.0
D;D;D
Polyphen
0.65
.;.;P
Vest4
0.46
MutPred
0.36
Loss of helix (P = 0.028);Loss of helix (P = 0.028);Loss of helix (P = 0.028);
MVP
0.59
MPC
0.28
ClinPred
0.58
D
GERP RS
-0.62
Varity_R
0.19
gMVP
0.38
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.22
Details are displayed if max score is > 0.2
DS_AL_spliceai
0.22
Position offset: -21

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs368419493; hg19: chr2-74717173; API